PON2 overexpression was detected in the pancreas, liver, kidney, and lung tumors and an over 10-fold upregulation of PON2 in thymus tumors and non-Hodgkin’s lymphomas [4]. The gene discussed is PON2; the disease is non-Hodgkin lymphoma.